• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对基于人群的癌症登记的影响。

Impact of the COVID-19 pandemic on population-based cancer registry.

机构信息

Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

Cancer Council Queensland, Brisbane, Queensland, Australia.

出版信息

Int J Cancer. 2022 Jan 15;150(2):273-278. doi: 10.1002/ijc.33792. Epub 2021 Sep 18.

DOI:10.1002/ijc.33792
PMID:34480348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8652711/
Abstract

The COVID-19 pandemic has caused disruptions to national health systems and impacted health outcomes worldwide. However, the extent to which surveillance systems, such as population-based cancer registration, have been affected was not reported. Here we sought to evaluate the effect of the pandemic on registry operations across different areas and development levels worldwide. We investigated the impact of COVID-19 on three main areas of cancer registry operations: staffing, financing and data collection. An online survey was administered to 750 member registries of the International Association for Cancer Registries. Among 212 responding registries from 90 countries, 65.6% reported a disruption in operations, ranging between 45% in south-eastern Asia and 87% in the Latin America and Caribbean. Active data collection was disrupted more than case notifications or hybrid methods. In countries categorized with low Human Development Index (HDI), a greater number of registries reported a negative impact (81.3%) than in very high HDI countries (57.8%). This contrast was highest in term of impact on financing: 9/16 (56%) registries in low HDI countries reported a current or an expected decline in funding, compared to 7/108 (7%) in very high HDI countries. With many cancer registries worldwide reporting disruption to their operations during the early COVID-19 pandemic, urgent actions are needed to ensure their continuity. Governmental commitment to support future registry operations as an asset to disease control, alongside a move toward electronic reporting systems will help to ensure the sustainability of cancer surveillance worldwide.

摘要

COVID-19 大流行扰乱了各国的卫生系统,并对全球的健康结果产生了影响。然而,有关人口癌症登记等监测系统受到何种程度影响的报道尚未见诸于文献。在此,我们旨在评估大流行对全球不同地区和发展水平的登记处业务的影响。我们研究了 COVID-19 对癌症登记业务三个主要领域的影响:人员配置、资金和数据收集。我们向国际癌症登记协会的 750 个成员登记处发放了在线调查。在来自 90 个国家的 212 个回应登记处中,有 65.6%报告业务中断,其中东南亚为 45%,拉丁美洲和加勒比地区为 87%。与病例通知或混合方法相比,主动数据收集受到的干扰更大。在人类发展指数(HDI)较低的国家中,报告负面影响的登记处比例(81.3%)高于 HDI 非常高的国家(57.8%)。这种差异在对资金的影响方面最为显著:在 HDI 较低的国家中,有 9/16(56%)的登记处报告当前或预计资金减少,而在 HDI 非常高的国家中,仅有 7/108(7%)的登记处报告资金减少。由于全世界许多癌症登记处报告在 COVID-19 大流行早期其业务受到干扰,因此需要采取紧急行动以确保其连续性。政府承诺将支持未来的登记处业务作为疾病控制的资产,同时转向电子报告系统,这将有助于确保全球癌症监测的可持续性。

相似文献

1
Impact of the COVID-19 pandemic on population-based cancer registry.COVID-19 大流行对基于人群的癌症登记的影响。
Int J Cancer. 2022 Jan 15;150(2):273-278. doi: 10.1002/ijc.33792. Epub 2021 Sep 18.
2
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
3
Leveraging a Cloud-Based Critical Care Registry for COVID-19 Pandemic Surveillance and Research in Low- and Middle-Income Countries.利用基于云的重症监护注册表进行 COVID-19 大流行监测和中低收入国家的研究。
JMIR Public Health Surveill. 2020 Nov 23;6(4):e21939. doi: 10.2196/21939.
4
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
5
The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis.2019年冠状病毒病疫情对癌症护理服务延误和中断的全球影响:一项系统综述和荟萃分析
Nat Cancer. 2025 Jan;6(1):194-204. doi: 10.1038/s43018-024-00880-4. Epub 2025 Jan 2.
6
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.非洲、中美洲和南美洲以及亚洲的癌症生存率(SURVCAN-3):一项基于32个国家人口的基准研究。
Lancet Oncol. 2023 Jan;24(1):22-32. doi: 10.1016/S1470-2045(22)00704-5.
7
The Effects of COVID-19 Pandemic on Trauma Registry and Performance Improvement Operations and Workforce Nationwide: A Survey of Trauma Center Association of America Members.新型冠状病毒肺炎大流行对创伤登记处和全国范围内绩效改进运作及劳动力的影响:对美国创伤中心协会成员的调查。
J Surg Res. 2022 May;273:24-33. doi: 10.1016/j.jss.2021.11.010. Epub 2021 Nov 27.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response.COVID-19 与癌症:基于登记数据的大流行应对措施综述。
JAMA Oncol. 2021 Dec 1;7(12):1882-1890. doi: 10.1001/jamaoncol.2021.4083.
10
The need for holistic, longitudinal and comparable, real-time assessment of the emotional, behavioral and societal impact of the COVID-19 pandemic across nations.需要对新冠疫情在各国造成的情感、行为和社会影响进行全面、纵向、可比的实时评估。
Psychiatriki. 2021 Apr 19;32(1):15-18. doi: 10.22365/jpsych.2021.010. Epub 2021 Mar 8.

引用本文的文献

1
Pediatric and Young Adult Cancer Incidence in the United States During the COVID-19 Pandemic.美国新冠疫情期间儿童及青年癌症发病率
Pediatr Blood Cancer. 2025 Aug 20:e31976. doi: 10.1002/pbc.31976.
2
Cancer Incidence and Mortality Across 43 Cancer Registries in India.印度43个癌症登记处的癌症发病率和死亡率
JAMA Netw Open. 2025 Aug 1;8(8):e2527805. doi: 10.1001/jamanetworkopen.2025.27805.
3
Causes of death among patients with metastatic differentiated thyroid cancer.转移性分化型甲状腺癌患者的死因
J Endocrinol Invest. 2025 Jul 7. doi: 10.1007/s40618-025-02643-z.
4
The COVID-19 pandemic increased the incidence of newly diagnosed cancers: evidence from a large cohort study in Southern Italy.新冠疫情增加了新诊断癌症的发病率:来自意大利南部一项大型队列研究的证据。
BMC Med. 2025 Jul 1;23(1):399. doi: 10.1186/s12916-025-04237-1.
5
Cancer Incidence in Kabul, Afghanistan: The First Report From the Population-Based Cancer Registry.阿富汗喀布尔的癌症发病率:基于人群的癌症登记处的首份报告。
Cancer Med. 2025 Apr;14(8):e70844. doi: 10.1002/cam4.70844.
6
Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027.2013年至2022年秘鲁及其地理区域的乳腺癌死亡率趋势以及至2027年的预测。
BMC Cancer. 2025 Mar 13;25(1):463. doi: 10.1186/s12885-025-13872-z.
7
Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries.2020 - 2021年新冠疫情期间北欧国家癌症发病率和分期的变化。
Acta Oncol. 2025 Feb 12;64:257-266. doi: 10.2340/1651-226X.2025.42079.
8
Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021.全球、区域和国家食管癌负担:全球疾病负担研究2021的系统分析
Biomark Res. 2025 Jan 6;13(1):3. doi: 10.1186/s40364-024-00718-2.
9
Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011-2019 based on a health insurance fund database.修订中欧某国的癌症发病率:一项基于健康保险基金数据库的2011 - 2019年匈牙利全国性研究。
Front Oncol. 2024 Oct 1;14:1393132. doi: 10.3389/fonc.2024.1393132. eCollection 2024.
10
The current and future cancer burden in the Gulf Cooperation Council (GCC) countries.海湾合作委员会(GCC)国家当前及未来的癌症负担
Cancer Med. 2024 Sep;13(17):e70141. doi: 10.1002/cam4.70141.

本文引用的文献

1
Population-Based Cancer Registration in Sub-Saharan Africa: Its Role in Research and Cancer Control.撒哈拉以南非洲地区基于人群的癌症登记:其在研究和癌症控制中的作用。
JCO Glob Oncol. 2020 Nov;6:1721-1728. doi: 10.1200/GO.20.00294.
2
Mortality due to cancer treatment delay: systematic review and meta-analysis.癌症治疗延迟导致的死亡率:系统评价与荟萃分析
BMJ. 2020 Nov 4;371:m4087. doi: 10.1136/bmj.m4087.
3
The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.由于 COVID-19 疫情而暂时暂停全国癌症筛查计划对荷兰乳腺癌和结直肠癌诊断的影响。
J Hematol Oncol. 2020 Nov 4;13(1):147. doi: 10.1186/s13045-020-00984-1.
4
Consequences of COVID-19 for cancer care - a CRUK perspective.COVID-19 对癌症治疗的影响——英国癌症研究中心的观点。
Nat Rev Clin Oncol. 2021 Jan;18(1):3-4. doi: 10.1038/s41571-020-00446-0.
5
Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care.COVID-19 对孤独感、心理健康和卫生服务利用的影响:初级保健中老年多病患者的前瞻性队列研究。
Br J Gen Pract. 2020 Oct 29;70(700):e817-e824. doi: 10.3399/bjgp20X713021. Print 2020 Nov.
6
Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study.新型冠状病毒肺炎疫情对荷兰外科乳腺癌治疗的影响:一项多中心回顾性队列研究。
Clin Breast Cancer. 2020 Dec;20(6):454-461. doi: 10.1016/j.clbc.2020.08.002. Epub 2020 Aug 7.
7
Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results.新冠疫情对斯洛文尼亚癌症诊断和管理的影响 - 初步结果。
Radiol Oncol. 2020 Jul 29;54(3):329-334. doi: 10.2478/raon-2020-0048.
8
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.《COVID-19 大流行对英国英格兰因诊断延误导致的癌症死亡人数的影响:一项全国性基于人群的建模研究》。
Lancet Oncol. 2020 Aug;21(8):1023-1034. doi: 10.1016/S1470-2045(20)30388-0. Epub 2020 Jul 20.
9
Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.2020 年因 COVID-19 大流行而实行的“封锁”期间的癌症诊断率与 2018-2019 年相比:一项来自细胞病理学的审计研究。
J Clin Pathol. 2021 Mar;74(3):187-189. doi: 10.1136/jclinpath-2020-206833. Epub 2020 Jun 19.
10
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.胸恶性肿瘤患者的 COVID-19(TERAVOLT):一项国际、基于登记的队列研究的初步结果。
Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12.